TXNRD1 and cancer: Despite the fact that earlier studies by other authors have repeatedly shown that inhibition of GPX1, GPX 4, and TXNRD1 contributed to increased oxidative stress in cancer cells [61,62,63,64], our results indicate an increase in their expression under the influence of the studied agents.